Oncology Collaborative
Membership
Chair: Executive Director Oncology Pharmacy Services, Rutgers Cancer Institute
of New Jersey
Co-Chair: Corporate Assistant Vice President of Pharmacy Operations
Members: Corporate Assistant Vice President of Integrated Pharmacy Services, Assistant
Director Pharmacy Operations, Pharmacy Operations Manager, IV Room Supervisors
and Oncology Pharmacists from the Acute Care Service Line
Meetings
The Oncology Collaborative shall meet quarterly or as otherwise deemed necessary by the chair.
How We Accomplish Our Goals
The Oncology Pharmacy Collaborative is a subcommittee of the Oncology P&T Committee and the Director’s Council. The Collaborative assists the Rutgers Cancer Institute/RWJBarnabas Health enterprise by evaluating the quality and safety of the delivery of pharmaceutical care to patients with the diagnosis of cancer or cancer related diseases. It is a single-disciplinary committee that is responsible for the assigned process of medication formulary review and contributing to the development of policies, procedures, and guidelines for medication management of cancer-related therapies within Rutgers Cancer Institute and RWJBarnabas. All functions are directed by and reported back to the main the Oncology P&T Committee and the Director’s Council.
Oncology Collaborative Membership
-
Michael P. Kane, RPh, BCOP
Executive Director, Oncology Pharmacy Services, Rutgers Cancer Institute of New Jersey Chair of Oncology Collaborative
-
Doug DeStefano, PharmD
Corporate Assistant Vice President of Pharmacy Operations Co-chair of Oncology Collaborative
-
Olubunmi Afolabi, PharmD, BCSCP
Sterile Products Supervisor, Cooperman Barnabas Medical Center
-
David Appel, PharmD
Pharmacy Operations Manager, RWJ University Hospital at Hamilton
-
David Awad, PharmD, BCOP
Pharmacy Specialist, Oncology, RWJ University Hospital at New Brunswick
-
Isabel Caratenuto, PharmD
Oncology Pharmacy Specialist, RWJ University Hospital at Somerset
-
Abiola Emmanuel, RPh
Lead Oncology Clinical Staff Pharmacist, Newark Beth Israel Medical Center
-
Elizabeth M. George, PharmD, BCOP
Pharmacist, RWJ University Hospital at New Brunswick
-
Jessica Koerner, PharmD, BCPS, BCACP, FASHP
Corporate Assistant Vice President of Integrated Pharmacy Services, Corporate Pharmacy
-
John Hoffman, PharmD
Assistant Director Pharmacy, Operations, Cooperman Barnabas Medical Center
-
Fuwing Lee, RPh, MPA, MSHI
Clinical Pharmacist Specialist, Rutgers Cancer Institute of New Jersey
-
Jiyeon Park, PharmD, BCOP
Clinical Pharmacist, Specialist-Heme/BMT, Rutgers Cancer Institute of New Jersey
-
Jigisha K. Patel, PharmD
Pharmacist, RWJ University Hospital at Somerset
-
Marcel Redhead, PharmD
Sterile Products Supervisor, Newark Beth Israel Medical Center
-
Denise Saul, RPh
Oncology Clinical Specialist, Newark Beth Israel Medical Center
-
Muhammad Shahid, PharmD, BCOP
Pharmacy Oncology Supervisor, Jersey City Medical Center
-
Simran Singh, PharmD, BCPS
Pharmacy Operations Supervisor, Clara Maass Medical Center
-
Kathleen Tondo, PharmD
IV Supervisor, Monmouth Medical Center
-
Susan Bruno, RPH
Oncology Pharmacist, RWJ University Hospital at Hamilton
-
Ashley Finamore, PharmD, BCOP
Clinical Pharmacist, Specialist, Rutgers Cancer Institute of New Jersey
-
Christian Gabel, PharmD
Pharmacist Manager, Investigational Drug Services, Rutgers Cancer Institute of New Jersey
-
Martin William Hesselbacher II, PharmD
Lead Pharmacist, Sterile Products Supervisor, Monmouth Medical Center Southern Campus
-
Esther Huang, PharmD, BCOP, BCPS
Clinical Pharmacist, Specialist-Heme/BMT, Rutgers Cancer Institute of New Jersey
-
Jonathan Lalli, PharmD, BCOP
Clinical Pharmacist, Specialist-Heme, Rutgers Cancer Institute of New Jersey
-
Jessica Stemple, PharmD, BCOP
Clinical Pharmacist, Specialist Rutgers Cancer Institute of New Jersey